Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Vestibular Schwannomas
NCT03079999Phase 2Active, not recruiting
- Sponsor
- Massachusetts Eye and Ear
- Start
- Mar 2018
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in vestibular schwannoma (VS), sponsored by Massachusetts Eye and Ear. Started Mar 2018; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT03079999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079999.